Source:http://linkedlifedata.com/resource/pubmed/id/10744603
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2000-3-29
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0003-4819
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
4
|
pubmed:volume |
132
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
593-4; author reply 594
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10744603-Adenoma,
pubmed-meshheading:10744603-Adrenal Gland Neoplasms,
pubmed-meshheading:10744603-Aldosterone,
pubmed-meshheading:10744603-Aldosterone Antagonists,
pubmed-meshheading:10744603-Humans,
pubmed-meshheading:10744603-Hypertension,
pubmed-meshheading:10744603-Spironolactone
|
pubmed:year |
2000
|
pubmed:articleTitle |
Medical management of aldosterone-producing adenomas.
|
pubmed:publicationType |
Letter,
Comment
|